» Articles » PMID: 32541670

Hematopoietic Stem and Progenitor Cell-restricted Cdx2 Expression Induces Transformation to Myelodysplasia and Acute Leukemia

Abstract

The caudal-related homeobox transcription factor CDX2 is expressed in leukemic cells but not during normal blood formation. Retroviral overexpression of Cdx2 induces AML in mice, however the developmental stage at which CDX2 exerts its effect is unknown. We developed a conditionally inducible Cdx2 mouse model to determine the effects of in vivo, inducible Cdx2 expression in hematopoietic stem and progenitor cells (HSPCs). Cdx2-transgenic mice develop myelodysplastic syndrome with progression to acute leukemia associated with acquisition of additional driver mutations. Cdx2-expressing HSPCs demonstrate enrichment of hematopoietic-specific enhancers associated with pro-differentiation transcription factors. Furthermore, treatment of Cdx2 AML with azacitidine decreases leukemic burden. Extended scheduling of low-dose azacitidine shows greater efficacy in comparison to intermittent higher-dose azacitidine, linked to more specific epigenetic modulation. Conditional Cdx2 expression in HSPCs is an inducible model of de novo leukemic transformation and can be used to optimize treatment in high-risk AML.

Citing Articles

miR-133a and miR-135a Regulate All-Trans Retinoic Acid-Mediated Differentiation in Pediatric Acute Myeloid Leukemia by Inhibiting CDX2 Translation and Serve as Prognostic Biomarkers.

Cheng Y, Fan Z, Liang C, Peng C, Li Y, Wang L Technol Cancer Res Treat. 2024; 23:15330338241248576.

PMID: 38693824 PMC: 11067685. DOI: 10.1177/15330338241248576.


Extended exposure to low doses of azacitidine induces differentiation of leukemic stem cells through activation of myeloperoxidase.

Jeyaraju D, Alapa M, Polonskaia A, Risueno A, Subramanyam P, Anand A Haematologica. 2023; 109(4):1082-1094.

PMID: 37941406 PMC: 10985425. DOI: 10.3324/haematol.2023.283437.


Cre recombinase expression cooperates with homozygous FLT3 internal tandem duplication knockin mouse model to induce acute myeloid leukemia.

Straube J, Eifert T, Vu T, Janardhanan Y, Haldar R, von Eyss B Leukemia. 2023; 37(4):741-750.

PMID: 36739348 PMC: 10079527. DOI: 10.1038/s41375-023-01832-0.


Regulation of the THRA gene, encoding the thyroid hormone nuclear receptor TRα1, in intestinal lesions.

Giolito M, La Rosa T, Farhat D, Bodoirat S, Guardia G, Domon-Dell C Mol Oncol. 2022; 16(22):3975-3993.

PMID: 36217307 PMC: 9718118. DOI: 10.1002/1878-0261.13298.


Why B(-)other? About the gap of unknowns in ALL.

Fioretos T Blood. 2022; 139(24):3455-3457.

PMID: 35708724 PMC: 9203700. DOI: 10.1182/blood.2022015993.


References
1.
Scholl C, Bansal D, Dohner K, Eiwen K, Huntly B, Lee B . The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis. J Clin Invest. 2007; 117(4):1037-48. PMC: 1810574. DOI: 10.1172/JCI30182. View

2.
Rawat V, Cusan M, Deshpande A, Hiddemann W, Quintanilla-Martinez L, Humphries R . Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemia. Proc Natl Acad Sci U S A. 2004; 101(3):817-22. PMC: 321764. DOI: 10.1073/pnas.0305555101. View

3.
Rawat V, Thoene S, Naidu V, Arseni N, Heilmeier B, Metzeler K . Overexpression of CDX2 perturbs HOX gene expression in murine progenitors depending on its N-terminal domain and is closely correlated with deregulated HOX gene expression in human acute myeloid leukemia. Blood. 2007; 111(1):309-19. DOI: 10.1182/blood-2007-04-085407. View

4.
Lengerke C, Daley G . Caudal genes in blood development and leukemia. Ann N Y Acad Sci. 2012; 1266:47-54. PMC: 3431192. DOI: 10.1111/j.1749-6632.2012.06625.x. View

5.
Chawengsaksophak K, de Graaff W, Rossant J, Deschamps J, Beck F . Cdx2 is essential for axial elongation in mouse development. Proc Natl Acad Sci U S A. 2004; 101(20):7641-5. PMC: 419659. DOI: 10.1073/pnas.0401654101. View